Select Publications
Conference Papers
, 2019, 'Evaluating outpatient elective paracentesis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 74 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Stereotactic body radiation therapy for portal vein tumor thrombus is a safe and valuable therapy for the palliation of advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 103 - 103, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100165&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Hepatitis B virus (HBV) DNA integration is not driven by viral proteins', in Zeitschrift für Gastroenterologie, Georg Thieme Verlag KG, presented at
, 2017, 'An Observational, Prospective Epidemiological Registry in Australia of HCV Liver Disease (OPERA-C)', in HEPATOLOGY, WILEY, DC, Washington, pp. 528A - 528A, presented at
, 2017, 'Can Quantitative HBsAg Threshold Predict High Viral Load and Risk of Mother to Child Transmission? Like Life, You Get What You Pay For', in HEPATOLOGY, WILEY, DC, Washington, pp. 1009A - 1010A, presented at
, 2017, 'Project ECHO in Australia: A novel tele-mentoring service to aid Hepatitis C treatment in difficult to access populations', in HEPATOLOGY, WILEY, DC, Washington, pp. 317A - 318A, presented at
, 2017, 'Can quantitative HBsAg threshold predict high viral load and risk of mother-to-child transmission? Like life, you get what you pay for', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 82 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 75 - 75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100139&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Project ECHO: A novel tele-mentoring service to aid hepatitis C treatment in difficult-to-access populations', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 67 - 67, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'EFFECT OF TENOFOVIR ON KEY HEPATITIS B VIRUS MARKERS IN PREGNANT WOMEN DURING THE THIRD TRIMESTER AND POSTPARTUM', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, pp. S565 - S565, presented at
, 2015, 'Survival benefits of multi-disciplinary team care in hepatocellular carcinoma at Liverpool Hospital, New South Wales, 2003–2013', in Journal of Gastroenterology and Hepatology, pp. 95 - 116, http://dx.doi.org/10.1111/jgh.13093
, 2014, 'The landscape of pregant women with hepatitis B in a single centre', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1010A - 1010A, presented at
, 2014, 'Treatment safety and efficacy of Boceprevir-based triple therapy in genotype 1 hepatitis C: the Australian multi-centre Boceprevir real world experience (SABRE-C)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 674A - 674A, presented at
, 2014, 'Understanding the Phases of Chronic Hepatitis B; the problem and a novel solution using renamed phases, the Hepatitis B Bear and a video (see " Understanding Hepatitis B " on YouTube)', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 1001A - 1002A, presented at
, 2014, 'The landscape of pregnant women with hepatitis B in a single center', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 77 - 77, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'Understanding the phases of chronic hepatitis B: the problem and a novel solution using renamed phases, the hepatitis B bear and a video (see "Understanding Hepatitis B" on YouTube)', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000168&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'RECURRENT CLOSTRIDIUM DIFFICILE INFECTION IN A RENAL TRANSPLANT RECIPIENT SUCCESSFULLY TREATED WITH FECAL MICROBIOTA TRANSPLANTATION', in Nephrology, Melbourne Convention and Exhibition Centre Melbourne, Australia, presented at
, 2014, 'RENAL FUNCTION TESTING IN PATIENTS ON TENOFOVIR ANTIVIRAL THERAPY', in NEPHROLOGY, WILEY-BLACKWELL, pp. 72 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'UTILITY OF QUANTITATIVE HEPATITIS B E ANTIGEN AND SURFACE ANTIGEN IN THE PREDICTION OF HEPATITIS B E ANTIGEN SEROCONVERSION FOLLOWING PREGNANCY IN HBV', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, ENGLAND, London, pp. S295 - S295, presented at
, 2013, 'Efficacy and safety of tenofovir in pregnancy to prevent Mother to Baby transmission of HBV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 625A - 625A, presented at
, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 641A - 642A, presented at
, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2013, 'Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: Lack of potency and selection of resistance mutations', in Journal of Viral Hepatitis, http://dx.doi.org/10.1111/jvh.12212
, 2012, 'Lamivudine in pregnancy: Impact on Hepatitis B flares and HBeAg seroconversion post partum', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at
, 2012, 'The Hepatitis B Bear: Novel patient orientated information enhances patient understanding of the phases of Hepatitis B', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 355A - 355A, presented at
, 2011, 'NUCLEOT(S)IDE ANALOGUES TO PREVENT PERINATAL TRANSMISSION OF HBV: LAMIVUDINE IS EFFECTIVE BUT TENOFOVIR MAY BE BETTER', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 892A - 892A, presented at
, 2011, 'ULTRA DEEP PYROSEQUENCING IDENTIFIES MULTIDRUG RESISTANT HBV IN PREGNANT WOMEN UNDERGOING LAMIVUDINE THERAPY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1074A - 1075A, presented at
, 2011, 'LAMIVUDINE IN LATE PREGNANCY FOR PREVENTION OF HBV TRANSMISSION: EFFECTIVENESS AND DETECTION OF ANTIVIRAL RESISTANCE', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S295 - S296, presented at
, 2009, 'QUANTITATIVE HBEAG AND HBSAG: LEVELS CORRELATE WITH HEPATITIS B VIRAL LOAD AND QUASI SPECIES SUGGESTING A SINGLE CONTROL MECHANISM', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 984A - 984A, presented at
, 2009, 'TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN CHRONIC HEPATITIS B INFECTION: REDUCE NUMBER OF BIOPSIES & SAVE MONEY', in HEPATOLOGY, JOHN WILEY & SONS INC, MA, Boston, pp. 543A - 543A, presented at
, 2008, 'HEPATITIS C IN DIALYSIS AND RENAL TRANSPLANT PATIENTS - ANALYSIS OF THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY REVEALS SIGNIFICANT IMPACT OF HEPATITIS C INFECTION AFTER RENAL TRANSPLANTATION', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 1130A - 1130A, presented at
, 2008, 'PERINATAL TRANSMISSION OF HEPATITIS B VIRUS: VIRAL LOAD AND HBEAG STATUS ARE SIGNIFICANT RISK FACTORS', in HEPATOLOGY, JOHN WILEY & SONS INC, CA, San Francisco, pp. 676A - 676A, presented at
, 2008, 'VIROLOGICAL HETEROGENEITY IN HEPATITIS B POSITIVE WOMEN; QUANTITATIVE HBeAg ESTIMATION DISTINGUISHES THOSE WITH SUBPOPULATIONS OF BASAL CORE PROMOTER MUTATIONS', in Journal of Hepatology, Elsevier Science BV, Amsterdam, Netherlands, pp. 365 - 366, presented at
, 2008, 'Correlates of HCV seronegative-immune status in high risk IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356
, 2008, 'Is there still a role for lamivudine? Baseline HBeAg status and viral load at 6 and 12 months predicts long-term effectiveness of lamivudine in CHB patients', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A186 - A186, presented at
, 2008, 'Modeling population-based chronic hepatitis B screening and treatment to prevent cirrhosis and liver cancer among high risk populations in Australia', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A359
, 2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347
, 2003, 'Intrahepatic expression of collagen and fibroblast activation protein (FAP) in hepatitis C virus infection', in Advances in Experimental Medicine and Biology, pp. 235 - 243
, 2000, 'Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV: Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activity', in Advances in Experimental Medicine and Biology, pp. 89 - 95